231 related articles for article (PubMed ID: 28548306)
1. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
[TBL] [Abstract][Full Text] [Related]
2. Zanthoxylum avicennae extracts inhibit cell proliferation through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells in vitro and in vivo.
Dung TD; Chang HC; Binh TV; Lee MR; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
Int J Mol Med; 2012 Jun; 29(6):1045-52. PubMed ID: 22426520
[TBL] [Abstract][Full Text] [Related]
3. Zanthoxylum avicennae extracts induce cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and block tumor growth in xenografted nude mice.
Dung TD; Chang HC; Chen CY; Peng WH; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
Int J Mol Med; 2011 Dec; 28(6):927-36. PubMed ID: 21874223
[TBL] [Abstract][Full Text] [Related]
4. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation.
Dung TD; Feng CC; Kuo WW; Pai P; Chung LC; Chang SH; Hsu HH; Tsai FJ; Lin YM; Huang CY
Biosci Biotechnol Biochem; 2013; 77(9):1814-21. PubMed ID: 24018669
[TBL] [Abstract][Full Text] [Related]
5. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and ERα enhanced β-catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK-3β and β-TrCP expression.
Chen YF; Velmurugan BK; Wang HL; Tu CC; Che RJ; Chen MC; Jen LB; Vishwanadha VP; Hsu HH; Huang CY
Environ Toxicol; 2017 Feb; 32(2):519-529. PubMed ID: 26990689
[TBL] [Abstract][Full Text] [Related]
7. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
8. Rhubarb inhibits hepatocellular carcinoma cell metastasis via GSK-3-β activation to enhance protein degradation and attenuate nuclear translocation of β-catenin.
Tsai KH; Hsien HH; Chen LM; Ting WJ; Yang YS; Kuo CH; Tsai CH; Tsai FJ; Tsai HJ; Huang CY
Food Chem; 2013 May; 138(1):278-85. PubMed ID: 23265488
[TBL] [Abstract][Full Text] [Related]
9. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
10. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
11. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/β-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect.
Hsieh CH; Cheng LH; Hsu HH; Ho TJ; Tu CC; Lin YM; Chen MC; Tsai FJ; Hsieh YL; Huang CY
Biosci Biotechnol Biochem; 2013; 77(12):2397-404. PubMed ID: 24317053
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
[TBL] [Abstract][Full Text] [Related]
13. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
[TBL] [Abstract][Full Text] [Related]
14. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
[TBL] [Abstract][Full Text] [Related]
15. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
16. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
Jiang J; Xu B; Zheng Y; Guo X; Chen F
Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
Lim K; Han C; Dai Y; Shen M; Wu T
Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
Ng L; Chow AKM; Man JHW; Yau TCC; Wan TMH; Iyer DN; Kwan VHT; Poon RTP; Pang RWC; Law WL
BMC Cancer; 2018 Jun; 18(1):621. PubMed ID: 29859044
[TBL] [Abstract][Full Text] [Related]
20. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
